Trial Profile
A Study Assessing the Safety and Efficacy of Daratumumab Based Therapies (DBT) in Heavily Pretreated Patients with AL Amyloidosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jun 2019
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Daratumumab (Primary) ; Dexamethasone (Primary) ; Lenalidomide (Primary) ; Pomalidomide (Primary)
- Indications Amyloid light-chain amyloidosis
- Focus Adverse reactions; Therapeutic Use
- 24 Jun 2018 New trial record
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology.